{"disease":{"id":"phenylketonuria","name":"phenylketonuria"},"drugs":{"marketed":[{"drug_id":"sapropterin","indication_name":"Classical phenylketonuria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kuvan","generic_name":"SAPROPTERIN","company_name":"BioMarin","drug_phase":"marketed","molecular_target":"Nitric oxide synthase, brain","drug_class":"Phenylalanine Hydroxylase Activator","quality_score":62,"revenue":"300","mechanism":"Kuvan works by activating the enzyme Phenylalanine Hydroxylase to break down phenylalanine."},{"drug_id":"pegvaliase","indication_name":"Phenylketonuria (PKU) Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PEGVALIASE","company_name":"","drug_phase":"marketed","molecular_target":"phenylalanine","drug_class":"Phenylalanine Metabolizing Enzyme [EPC]","quality_score":10,"revenue":null,"mechanism":"Pegvaliase-pqpz converts phenylalanine to ammonia and trans-cinnamic acid, reducing blood phenylalanine levels in PKU patients."},{"drug_id":"sepiapterin","indication_name":"sepiapterin-responsive phenylketonuria (PKU)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sephience","generic_name":"SEPIAPTERIN","company_name":"Ptc Therap","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":46,"revenue":null,"mechanism":"Sephience works by replenishing tetrahydrobiopterin (BH4), a critical cofactor for amino acid metabolism."},{"drug_id":"tetrahydrobiopterin","indication_name":"Classical phenylketonuria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Tetrahydrobiopterin","company_name":"University of Massachusetts, Worcester","drug_phase":"discontinued","molecular_target":"Nitric oxide synthase, brain, Phenylalanine-4-hydroxylase","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"palynziq","indication_name":"Classical phenylketonuria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Palynziq","company_name":"Emory University","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05813678","title":"A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":false},{"nct_id":"NCT01889862","title":"Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":true},{"nct_id":"NCT05128149","title":"Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University Children's Hospital, Zurich","has_results":false},{"nct_id":"NCT06305234","title":"A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":false},{"nct_id":"NCT05166161","title":"A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"PTC Therapeutics","has_results":false},{"nct_id":"NCT06901323","title":"Effect of L-carnitine Supplementation on Phenylalanine and Brain-derived Neurotrophic Factor Levels in Infants and Children With Phenylketonuria","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":176,"lead_sponsor_name":"Mansoura University","has_results":false},{"nct_id":"NCT05099640","title":"A Study of PTC923 in Participants With Phenylketonuria","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT05781399","title":"First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":135,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT06971731","title":"A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT03820804","title":"Nutritional Status in Phenylketonuria","phase":"","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Universidade do Porto","has_results":false},{"nct_id":"NCT03788343","title":"Phenylalanine and Its Impact on Cognition","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT06969209","title":"Brain Aging in Phenylketonuria","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT04943393","title":"Remote Neurocognitive and Psychological Assessment in PKU","phase":"","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT06792240","title":"Iron Supplements Effect on b-Phe Levels in PKU Patients During 3 Years Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"ASST Santi Paolo e Carlo","has_results":false},{"nct_id":"NCT03858101","title":"SNAP: Study Nutrients in Adult PKU","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Nutricia Research","has_results":false},{"nct_id":"NCT03516487","title":"Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Synlogic","has_results":false},{"nct_id":"NCT04248062","title":"Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism","phase":"","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"University Children's Hospital, Zurich","has_results":false},{"nct_id":"NCT00924703","title":"Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":true},{"nct_id":"NCT03505125","title":"A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":false},{"nct_id":"NCT06302348","title":"A Study of Sepiapterin in Participants With Phenylketonuria (PKU)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"PTC Therapeutics","has_results":false},{"nct_id":"NCT05579548","title":"A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":false},{"nct_id":"NCT04969809","title":"Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria Patients","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University Medical Centre Ljubljana","has_results":false},{"nct_id":"NCT06718842","title":"Walking Program in Fatty Liver Children With Phenylketonuria","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT04879277","title":"Study of Low-grade Systemic Inflammation in Adult Patients With Phenylketonuria","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT06941532","title":"GMP Powdered Substitutes in PKU and TYR","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Nutricia UK Ltd","has_results":false},{"nct_id":"NCT05894122","title":"Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®)","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT04086511","title":"PANDA: PKU Amino Acid Evaluation","phase":"","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Nutricia Research","has_results":false},{"nct_id":"NCT03694353","title":"Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":true},{"nct_id":"NCT07220265","title":"Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers","phase":"NA","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT05497050","title":"The Effect of Nursing Empowerment Program","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Cukurova University","has_results":false},{"nct_id":"NCT05764239","title":"Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Synlogic","has_results":true},{"nct_id":"NCT02555579","title":"Simplified Diet Approach in Phenylketonuria","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"University of Nebraska","has_results":false},{"nct_id":"NCT05972629","title":"A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT04251494","title":"A Study Into the Future Cardiovascular Disease (CVD) Risk of Phenylketonuria (PKU) Patients on a Low Phenylalanine Treatment Diet (LPD).","phase":"","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT04452513","title":"A Prospective Clinical Study of Phenylketonuria (PKU)","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":false},{"nct_id":"NCT05998109","title":"PheCheck Feasibility Study","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Lumos Diagnostics","has_results":false},{"nct_id":"NCT06560736","title":"Development of Novel Psychological Assessment Tools and Anxiety Intervention for Phenylketonuria","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT07406009","title":"The Psychosocial Functioning of Adults With Phenylketonuria.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT05051657","title":"Evaluation of the Express Plus Range","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Vitaflo International, Ltd","has_results":false},{"nct_id":"NCT03419819","title":"Evaluation of PKU Sphere","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Vitaflo International, Ltd","has_results":false},{"nct_id":"NCT03309345","title":"Body Composition, Energy Intake and Expenditure in People With Phenylketonuria","phase":"","overall_status":"UNKNOWN","enrollment_count":26,"lead_sponsor_name":"University of Glasgow","has_results":false},{"nct_id":"NCT03168399","title":"Evaluation of PKU Explore","phase":"NA","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Vitaflo International, Ltd","has_results":false},{"nct_id":"NCT04348708","title":"Long-Term Follow Up Study of Subjects Previously Administered HMI 102","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":21,"lead_sponsor_name":"Homology Medicines, Inc","has_results":false},{"nct_id":"NCT05827536","title":"Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.","phase":"NA","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"APR Applied Pharma Research s.a.","has_results":true},{"nct_id":"NCT07255599","title":"Evaluation of BH4 Responsiveness in Our PKU Patients","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT05971563","title":"Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Birmingham Women's and Children's NHS Foundation Trust","has_results":false},{"nct_id":"NCT06940193","title":"A Self-test Home-use Blood Phenylalanine Monitoring System Under the Brand Name Egoo Phe System Has Been Developed for Measurement of Phenylalanine (Phe) in Individuals Diagnosed With Phenylketonuria (PKU): The Study Purpose is to Evaluate Accuracy and Usability","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":20,"lead_sponsor_name":"Egoo Health Aps","has_results":false},{"nct_id":"NCT04534842","title":"Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Synlogic","has_results":false},{"nct_id":"NCT05096988","title":"Evaluation of PKU Sphere Liquid","phase":"NA","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Vitaflo International, Ltd","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}